JAK1 and liver dysplastic nodule: We first found that miR-200a-3p could target and regulate JAK1, and after inhibiting JAK1, it was found that JAK1 could further enhance the therapeutic effect of DHI on db/db mice and DR cells, suggesting that JAK1, as same as miR-200a-3p, was associated with the regulation of the development of DN and DR.